STRO
Price
$0.82
Change
-$0.09 (-9.89%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
69.61M
63 days until earnings call
TCRX
Price
$1.66
Change
-$0.12 (-6.74%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
93.94M
69 days until earnings call
Interact to see
Advertisement

STRO vs TCRX

Header iconSTRO vs TCRX Comparison
Open Charts STRO vs TCRXBanner chart's image
Sutro Biopharma
Price$0.82
Change-$0.09 (-9.89%)
Volume$2.92K
Capitalization69.61M
TScan Therapeutics
Price$1.66
Change-$0.12 (-6.74%)
Volume$4.83K
Capitalization93.94M
STRO vs TCRX Comparison Chart
Loading...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STRO vs. TCRX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STRO is a Buy and TCRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (STRO: $0.82 vs. TCRX: $1.66)
Brand notoriety: STRO and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STRO: 85% vs. TCRX: 34%
Market capitalization -- STRO: $69.61M vs. TCRX: $93.94M
STRO [@Biotechnology] is valued at $69.61M. TCRX’s [@Biotechnology] market capitalization is $93.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STRO’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • STRO’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, TCRX is a better buy in the long-term than STRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STRO’s TA Score shows that 6 TA indicator(s) are bullish while TCRX’s TA Score has 5 bullish TA indicator(s).

  • STRO’s TA Score: 6 bullish, 2 bearish.
  • TCRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, STRO is a better buy in the short-term than TCRX.

Price Growth

STRO (@Biotechnology) experienced а -8.42% price change this week, while TCRX (@Biotechnology) price change was +12.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

STRO is expected to report earnings on Aug 07, 2025.

TCRX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCRX($93.9M) has a higher market cap than STRO($69.6M). TCRX YTD gains are higher at: -41.447 vs. STRO (-50.576). TCRX has higher annual earnings (EBITDA): -124.58M vs. STRO (-203.18M). TCRX (252M) and STRO (249M) have equal amount of cash in the bank . STRO has less debt than TCRX: STRO (21.4M) vs TCRX (97M). STRO has higher revenues than TCRX: STRO (66.4M) vs TCRX (4.42M).
STROTCRXSTRO / TCRX
Capitalization69.6M93.9M74%
EBITDA-203.18M-124.58M163%
Gain YTD-50.576-41.447122%
P/E RatioN/AN/A-
Revenue66.4M4.42M1,502%
Total Cash249M252M99%
Total Debt21.4M97M22%
FUNDAMENTALS RATINGS
STRO: Fundamental Ratings
STRO
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
STROTCRX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPEV20.370.74
+3.77%
XPeng
CVX137.37-2.18
-1.56%
Chevron Corp
OSUR2.90-0.06
-2.03%
OraSure Technologies
IMCR37.70-0.94
-2.43%
Immunocore Holdings plc
VATE5.61-0.19
-3.28%
INNOVATE Corp

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with ALGS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then ALGS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
-0.43%
ALGS - STRO
44%
Loosely correlated
+5.71%
TRDA - STRO
41%
Loosely correlated
-3.76%
TCRX - STRO
41%
Loosely correlated
+1.71%
ERAS - STRO
40%
Loosely correlated
+5.88%
ATXS - STRO
40%
Loosely correlated
+6.45%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with IMNM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+1.71%
IMNM - TCRX
46%
Loosely correlated
-2.59%
FATE - TCRX
45%
Loosely correlated
+4.41%
PRME - TCRX
42%
Loosely correlated
-0.75%
STRO - TCRX
42%
Loosely correlated
-0.43%
MGNX - TCRX
42%
Loosely correlated
-0.66%
More